Evidence map›Paper›PMID 36165745›Full record

ArticleEuropean journal of endocrinology2022

Global psychological assessment with the evaluation of life and sleep quality and sexual and cognitive function in a large number of patients with acromegaly: a cross-sectional study.

Rosario Pivonello, Renata Simona Auriemma, Alessandra Delli Veneri, Francesca Dassie, Riccardina Lorusso, Marta Ragonese, Marco Liotta, Elisa Sala, Barbara Zarino, Elisa Lai and 7 more

Open access · hybridAbstract read
In one paragraph

Article in European journal of endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Anxiety, depression and acromegaly: a systematic review.Journal of endocrinological investigation · 2025
    Pooled it
  3. Trial
  4. Review
  5. The acromegaly patient experience: burden of treatment and quality of life.The Journal of clinical endocrinology and metabolism · 2026
    Review
  6. Review
  7. Article
  8. Acromegaly and Morris Syndrome: Description of a Clinical CaseEndocrine, metabolic & immune disorders drug targets · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Cognition and psychological wellbeing in hypopituitary patients.Reviews in endocrine & metabolic disorders · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 1 country.

Rosario PivonelloDipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Università Federico II di Napoli, Naples, Italy.ORCID 0000-0002-9632-1348
Renata Simona AuriemmaDipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Università Federico II di Napoli, Naples, Italy.
Alessandra Delli VeneriDipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Università Federico II di Napoli, Naples, Italy.
Francesca DassieDepartment of Medicine, Clinica Medica 3^, University of Padua, Padua, Italy.
Riccardina LorussoDepartment of Medicine, Clinica Medica 3^, University of Padua, Padua, Italy.
Marta RagoneseEndocrine Unit, University Hospital 'G. Martino', Messina, Italy.
Marco LiottaEndocrine Unit, University Hospital 'G. Martino', Messina, Italy.
Elisa SalaEndocrinology Unit.
Barbara ZarinoNeurosurgery Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Elisa LaiPsychology Unit, Department of Surgical, Medical, Molecular, and Critical Area Pathology, University of Pisa, Pisa, Italy.
Claudio UrbaniEndocrinology II Unit, Department of Medicine, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
Fausto BogazziEndocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Giovanna MantovaniEndocrinology Unit.
Salvatore CannavòEndocrine Unit, University Hospital 'G. Martino', Messina, Italy.
Pietro MaffeiDepartment of Medicine, Clinica Medica 3^, University of Padua, Padua, Italy.
Paolo ChiodiniMedical Statistic Unit, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Annamaria ColaoDipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Università Federico II di Napoli, Naples, Italy.
University of Padua · ITFederico II University Hospital · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITUniversity of Naples Federico II · ITUniversity of Pisa · ITAzienda Ospedaliera Universitaria Pisana · ITUniversity of Campania "Luigi Vanvitelli" · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Acromegaly is associated with somatic disfigurements which impair self-perception of well-being and quality of life. Nowadays, limited data are available on the interplay between hormonal excess and psychological discomfort. The study aimed at investigating the psychological profile, sleep quality, sexual function, cognitive functions, and quality of life in patients with acromegaly. Methods: In 223 acromegaly patients from 5 referral centres, global psychological profile, sleep quality, sexual function, cognitive function, and quality of life were investigated. Results: Depression was found in ~30% of patients, and anxiety in two-thirds, together with severe discomfort in body image mainly in women. Obstructive sleep apnoea syndrome risk and sleep disorders were found in >50% of patients and daily sleepiness in ~20%. Sexual dysfunction was reported in most of the patients, with the most severe impairment in women. Cognitive functions were compromised in ~10% of cases. Disease duration and patient's age and gender were the main determinants of these psychopathological conditions. Depression (P = 0.047), somatic-affective mood lowering (P = 0.021), state (P < 0.001) and trait (P = 0.013) anxiety, and body image distortion in body uneasiness test A (P < 0.001) and B (P = 0.006) were significantly worsened in patients <45 years and slightly worsened in those with disease duration less than 2 years. Male (P < 0.001) and female (P < 0.001) sexual function scores were significantly worsened in patients aged >64 years and slightly worsened in those with disease duration for more than 10 years, particularly in presence of cardiometabolic and respiratory complications. Cognitive symptoms were slightly worsened in older patients and in those with long disease duration. Conclusions: Acromegaly is associated with a relevant impairment of psychological profile persisting despite remission and long-term medical treatment.

Indexed as

AcromegalyQuality of LifeAgedCognitionCross-Sectional StudiesFemaleHumansMaleSleep Quality

Identifiers

PMID36165745
PMCPMC9782455
OpenAlexW4297255431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.